Table 1 presents the demographic, clinical, and biochemical data (excluding serum levels of MMP-3) of the RA patients during the 15-month TNFαI therapy, which were obtained in our previous investigations [24,25]. Here, MMP3 is linked to rheumatoid arthritis.